• Y-27632 dihydrochloride: Reliable ROCK Inhibitor for Cell As

  2026-06-07

  Discover how Y-27632 dihydrochloride (SKU A3008) advances cell viability, proliferation, and cytoskeletal studies with reproducible ROCK inhibition. This article addresses real laboratory challenges and offers scenario-driven, data-backed solutions for optimizing sensitive cellular workflows.

• Small-Molecule uPAR Inhibitors Block Cancer Cell Invasion

  2026-06-06

  Khanna et al. report the discovery of small-molecule inhibitors targeting the urokinase receptor (uPAR), specifically disrupting the uPAR·uPA interaction central to cancer cell invasion and metastasis. Their structure-guided approach demonstrates that molecules like IPR-803 block tumor invasion in breast cancer models, providing a foundation for targeted anti-metastatic strategies.

• Gepotidacin (GSK2140944): Driving Next-Gen Antibacterial Res

  2026-06-05

  Gepotidacin (GSK2140944) is revolutionizing antibacterial research by uniquely inhibiting bacterial DNA replication, even in fluoroquinolone-resistant strains. This article unpacks practical workflows, protocol insights, and troubleshooting strategies to maximize the impact of Gepotidacin in both in vitro and translational studies.

• Reelin-SFK Pathway Is Essential for Ketamine’s Antidepressan

  2026-06-05

  This study demonstrates that synaptic Reelin signaling, via Apoer2 and Src family kinases (SFKs), is necessary for ketamine-induced synaptic plasticity and behavioral antidepressant responses. The findings highlight a mechanistic basis for nonresponsiveness in treatment-resistant depression and offer new directions for translational research.

• JC-1: Gold-Standard Probe for Mitochondrial Membrane Potenti

  2026-06-04

  JC-1 is a ratiometric fluorescent dye for sensitive mitochondrial membrane potential assays, providing robust metrics for apoptosis detection and cellular bioenergetics studies. Its aggregation-dependent emission shift allows discrimination of mitochondrial integrity in diverse research models.

• Ceftolozane/Tazobactam: Innovation Against Resistant Gram-Ne

  2026-06-04

  The reference paper presents ceftolozane/tazobactam, a novel cephalosporin/β-lactamase inhibitor combination, as a significant advance for treating complicated intraabdominal and urinary tract infections, especially those caused by multidrug-resistant gram-negative bacteria. The study details its unique mechanism, pharmacodynamics, and comparative advantages over existing agents, providing actionable insights for researchers and clinicians confronting antibiotic resistance.

• Cefodizime in Clinical Resistance Surveillance: A New Paradi

  2026-06-03

  Explore how Cefodizime, a third-generation cephalosporin antibiotic, is reshaping resistance surveillance and antimicrobial stewardship. This article uniquely connects recent hospital surveillance data, practical assay considerations, and immunomodulatory insights to advance your research.

• N1-Methyl-Pseudouridine-5'-Triphosphate in Advanced RNA Work

  2026-06-03

  N1-Methyl-Pseudouridine-5'-Triphosphate empowers researchers to synthesize highly stable, translationally efficient RNA, unlocking reproducible results in mRNA vaccine development and RNA-protein assays. Learn how modern labs integrate this modified nucleoside triphosphate for enhanced workflow reliability and troubleshooting success.

• Parathyroid hormone (1-34) (human): New Frontiers in Calcifi

  2026-06-02

  Explore the multifaceted role of Parathyroid hormone (1-34) (human) in bone metabolism, vascular calcification, and endothelial-to-mesenchymal transition. This in-depth article reveals novel insights for assay design and disease modeling, setting it apart from standard osteoporosis and kidney research discussions.

• Trypsin in Cell Culture: Serine Protease Workflows & Innovat

  2026-06-02

  Trypsin, a serine protease, is indispensable for precise cell dissociation, advanced proteolytic assays, and membrane fusion studies. This article delivers actionable workflows, troubleshooting strategies, and a translational outlook—bridging foundational enzymology with next-generation cancer research and viral pathogenesis.

• Cefodizime (SKU BA1050): Reliable Antibacterial Solutions in

  2026-06-01

  This article addresses key laboratory challenges faced by biomedical researchers and lab technicians performing cell viability, proliferation, and cytotoxicity assays involving bacterial infection models. Using real experimental scenarios, it demonstrates how Cefodizime (SKU BA1050) from APExBIO delivers reproducible antimicrobial activity, workflow compatibility, and validated performance, supporting reliable outcomes in microbiology research.

• Escitalopram Applications in Antidepressant and Anxiolytic R

  2026-06-01

  Escitalopram, a highly selective SSRI, is pivotal for dissecting serotonergic mechanisms in advanced antidepressant and anxiolytic research. This article details experimental protocols, translational insights, and practical troubleshooting for leveraging APExBIO's high-purity Escitalopram in impactful neuroscience workflows.

• Gepotidacin for Uncomplicated Gonorrhea: Phase 2 Efficacy In

  2026-05-31

  The referenced phase 2 trial evaluates gepotidacin, a novel bacterial type II topoisomerase inhibitor, as a single-dose oral therapy for uncomplicated urogenital gonorrhea. With ≥95% efficacy and favorable safety, the study highlights gepotidacin’s potential in combating multidrug-resistant Neisseria gonorrhoeae, a global public health concern.

• Bobcat339: Next-Generation TET Inhibitor for Epigenetic Mech

  2026-05-30

  Discover how Bobcat339, a cytosine structure-based TET enzyme inhibitor, enables precise, mechanism-driven advances in DNA methylation regulation and gene transcription studies. This article uniquely explores Bobcat339’s role in unraveling epigenetic regulatory networks and optimizing experimental design for disease modeling.

• Mechanisms of pH-Induced Changes in the Lassa Virus Spike Co

  2026-05-29

  Katz et al. reveal atomic-level mechanisms for pH-dependent conformational changes in the Lassa virus spike, mapping early and late structural transitions and identifying a novel inhibitory mechanism of ARN-75039. These findings clarify viral entry processes and offer new targets for antiviral development.

414 records 13/28 page Previous Next First page 上5页 1112131415 下5页 Last page